Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)

Active
No
Status
Posted
Published Date
February 6th, 2024
Close Date
June 13th, 2024
Award Ceiling
$500,000.00
Opportunity No.
RFA-AG-25-016

Agency

National Institutes of Health (HHS-NIH11)

Eligible Applicants

Others

Funding Category

Health

Funding Instrument

Grant

Opportunity Category

Discretionary

Cost Sharing or Matching Requirement

Yes

Summary

The National Institutes of Health (NIH) has posted a grant opportunity titled "Multi-Scale Models Bridging Levels of Analysis in Aging and Alzheimer's Disease (AD) and AD-Related Dementias (ADRD) (R01 Clinical Trial Not Allowed)". This grant aims to fund the establishment of multi-scale computational models that can simulate the dynamic changes associated with aging, Alzheimer's disease, and Alzheimer's disease-related dementias (AD/ADRD). The models should utilize various computational approaches such as mathematical and computational modeling, image analysis, artificial intelligence, and machine learning. The goal is to gain a better understanding of the aging processes and AD/ADRD at the molecular, cellular, network, cognitive, and behavioral levels. The grant does not require cost sharing or matching. The maximum award ceiling is $500,000. Other eligible applicants, in addition to academic institutions, include Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), eligible agencies of the Federal Government, faith-based or community-based organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), non-domestic (non-U.S.) entities (Foreign Organizations), regional organizations, Tribally Controlled Colleges and Universities (TCCUs), and U.S. Territories or Possessions. The closing date for applications is June 13, 2024. For more information and to apply, visit the following link: http://grants.nih.gov/grants/guide/rfa-files/RFA-AG-25-016.html. For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.

Description

The purpose of this funding opportunity is to invite applications proposing to establish multi-scale computational models recapitulating dynamic changes associated with aging and Alzheimers disease and Alzheimers disease-related dementias (AD/ADRD). This broad scope encompasses a variety of computational approachessuch as mathematical and computational modeling, image analysis, artificial intelligence, and machine learningto better understand aging processes and AD/ADRD across molecules, cells and networks, and cognition and behavior.

Contact Information

Attachments
0 KB

Opportunity Lifecycle

Title
Type
Grant

Similar Opportunities

Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Mechanistic Investigations into ADRD Multiple Etiology Dementias (R01 - Clinical Trial Not Allowed)". This grant is in the category of Health and falls under the funding instrument type of Grant. The grant does not require cost sharing or matching. The opportunity is discretionary and falls under CFDA number 93.866. The purpose of this grant is to support investigations into the cellular and molecular mechanisms of how and why multi-proteinopathy interactions drive worsening neurodegenerative processes and phenotypic outcomes in dementias with multiple etiologies. The grant aims to identify the mechanisms of co-pathology cellular and molecular interactions across brain regions and time, as well as determine the events that lead to worse phenotypic outcomes. The investigations should focus on a minimum of two relevant co-pathologies, such as tau, alpha-synuclein, TDP-43, TMEM106B, and vascular, with optional risk factors and co-morbidities. The grant is open to eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments (Other than Federally Recognized), Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. Non-domestic (non-U.S.) Entities (Foreign Organizations) and non-U.S. components of U.S. Organizations are not eligible to apply. The grant has an award ceiling of $500,000. The closing date for applications is October 4, 2024, and the archive date is November 9, 2024. For more information and to apply, please visit the following link: [http://grants.nih.gov/grants/guide/pa-files/PAR-24-147.html](http://grants.nih.gov/grants/guide/pa-files/PAR-24-147.html). For any inquiries, please contact NIH Grants Information at grantsinfo@nih.gov.
Pilot Studies for the Spectrum of Alzheimers Disease/Alzheimers Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health is offering a grant opportunity titled "Pilot Studies for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline (R61 Clinical Trial Optional)". This grant aims to support research projects that collect pilot data to test pharmacological and non-pharmacological interventions for cognitive and neuropsychiatric changes associated with age-related cognitive decline, Alzheimer's disease (AD), and Alzheimer's disease-related dementias (ADRD). The funding opportunity seeks to stimulate studies that enhance trial design and methods. The grant does not require cost sharing or matching. The maximum award ceiling is $325,000. The eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The closing date for applications is November 18, 2024. For more information and to apply, visit the following link: [Pilot Studies for the Spectrum of Alzheimer's Disease/Alzheimer's Disease-Related Dementias and Age-Related Cognitive Decline Grant](http://grants.nih.gov/grants/guide/pa-files/PAR-23-083.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Early and Late Stage Clinical Trials for the Spectrum of Alzheimers Disease/Alzheimers Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Early and Late Stage Clinical Trials for the Spectrum of Alzheimer's Disease/Alzheimer's Related Dementias and Age-Related Cognitive Decline (R01 Clinical Trial Optional)". This grant aims to support the development and implementation of clinical trials for cognitive and neuropsychiatric changes associated with age-related cognitive decline, Alzheimer's disease (AD), and Alzheimer's disease-related dementias (ADRD). The trials will cover the entire spectrum of the disease, from pre-symptomatic to more severe stages. The funding will be used to explore both pharmacological and non-pharmacological interventions. The NIH is particularly interested in proposals that enhance trial design and methods. The grant does not require cost sharing or matching. The eligible applicants include various institutions and organizations, such as Alaska Native and Native Hawaiian Serving Institutions, Faith-based or Community-based Organizations, and U.S. Territories or Possessions. The deadline for applications is January 7, 2025. For more information and to apply, visit the NIH grants website at [http://grants.nih.gov/grants/guide/pa-files/PAR-23-081.html](http://grants.nih.gov/grants/guide/pa-files/PAR-23-081.html). For any inquiries, contact NIH Grants Information at grantsinfo@nih.gov.
Functional Target Validation for Alzheimer's Disease-Related Dementias (R61/R33 Clinical Trial Not Allowed)
National Institutes of Health
The National Institutes of Health (NIH) has posted a grant opportunity titled "Functional Target Validation for Alzheimer's Disease-Related Dementias (R61/R33 Clinical Trial Not Allowed)". This grant aims to support the comprehensive functional validation of newly identified therapeutic target candidates for Alzheimer's Disease-Related Dementias (ADRDs). The goal is to de-risk subsequent translational research and accelerate the development of novel therapies for ADRD. The grant will provide support for the development of customized technologies, models, and protocols to modulate the expression or activity of target candidates in cells or tissues and monitor their functional biological consequences in in vitro or in vivo disease models. The impact of the target modulation will be measured and cross-validated in different modalities across collaborating laboratories. The grant is open to eligible applicants, including Alaska Native and Native Hawaiian Serving Institutions, Asian American Native American Pacific Islander Serving Institutions (AANAPISISs), Eligible Agencies of the Federal Government, Faith-based or Community-based Organizations, Hispanic-serving Institutions, Historically Black Colleges and Universities (HBCUs), Indian/Native American Tribal Governments, Non-domestic (non-U.S.) Entities (Foreign Organizations), Regional Organizations, Tribally Controlled Colleges and Universities (TCCUs), U.S. Territory or Possession. The deadline for applications is November 8, 2024. For more information, please visit the [grant opportunity website](http://grants.nih.gov/grants/guide/rfa-files/RFA-NS-25-011.html).